Humoral and cellular responses to repeated COVID-19 exposure in multiple sclerosis patients receiving B-cell depleting therapies: a single-center, one-year, prospective study

Multiple sclerosis patients treated with anti-CD20 therapy (aCD20-MS) are considered especially vulnerable to complications from SARS-CoV-2 infection due to severe B-cell depletion with limited viral antigen-specific immunoglobulin production. Therefore, multiple vaccine doses as part of the primary...

Descripción completa

Detalles Bibliográficos
Autores principales: Alfonso-Dunn, Roberto, Lin, Jerry, Lei, Joyce, Liu, Jiayuan, Roche, Morgan, De Oliveira, Antonia, Raisingani, Amol, Kumar, Anjali, Kirschner, Vanessa, Feuer, Grant, Malin, Michaela, Sadiq, Saud A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338057/
https://www.ncbi.nlm.nih.gov/pubmed/37449202
http://dx.doi.org/10.3389/fimmu.2023.1194671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338057/
https://www.ncbi.nlm.nih.gov/pubmed/37449202
http://dx.doi.org/10.3389/fimmu.2023.1194671

Ejemplares similares